Comparison of treatment models for single primary advanced gallbladder cancer
Even when optimal treatment model cannot be pursued, providing comprehensive combinations of treatments to advanced GBC patients whenever possible is always beneficial for their survival.
Authors
- Tao Yan (ORCID: https://orcid.org/0000-0003-1472-4731)
- Bolun Ai
- Rongxuan Li
- Bingchen Wang (ORCID: https://orcid.org/0000-0002-3194-6769)
- Min Fan (ORCID: https://orcid.org/0000-0002-2639-2415)
- Xiaohong Chen (ORCID: https://orcid.org/0000-0002-9797-8384)
- Jianguo Zhou (ORCID: https://orcid.org/0000-0002-3990-7289)
- Da‐Yong Cao (ORCID: https://orcid.org/0000-0002-9518-1646)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3389/fimmu.2024.1500091
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57